Search research articles
Contact Us
Filters
Showing results (81-90 of 178) with videos related to
Page
of 18
Sort By:
Current Neurology and Neuroscience Reports
|
June 12, 2009
New insights into the organization of the basal ganglia
James B Koprich, Tom H Johnston, Philippe Huot, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
September 9, 2010
The α₂ adrenergic antagonist fipamezole improves quality of levodopa action in Parkinsonian primates
Tom H Johnston, Susan H Fox, Matthew J Piggott, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
March 15, 2006
Histamine H3 receptor agonists reduce L-dopa-induced chorea, but not dystonia, in the MPTP-lesioned nonhuman primate model of Parkinson's disease
Jordi Gomez-Ramirez, Tom H Johnston, Naomi P Visanji, et al.
Current Neurology and Neuroscience Reports
|
January 20, 2017
Integrating Patient Concerns into Parkinson's Disease Management
Shen-Yang Lim, Ai Huey Tan, Susan H Fox, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 17, 2010
Reduction of L-DOPA-induced dyskinesia by the selective metabotropic glutamate receptor 5 antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease
Tom H Johnston, Susan H Fox, Matthew J McIldowie, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
January 16, 2018
Botulinum Toxin Type A for Pain in Advanced Parkinson's Disease
Veronica Bruno, Maria Eliza Freitas, Deborah Mancini, et al.
JAMA Neurology
|
September 23, 2024
Four-Repeat Tau Seeding in the Skin of Patients With Progressive Supranuclear Palsy
Ivan Martinez-Valbuena, M Carmela Tartaglia, Susan H Fox, et al.
Neurobiology of Aging
|
November 6, 2010
Regulation of cortical and striatal 5-HT1A receptors in the MPTP-lesioned macaque
Philippe Huot, Tom H Johnston, James B Koprich, et al.
Neurobiology of Disease
|
January 3, 2009
Dopamine D3 receptor stimulation underlies the development of L-DOPA-induced dyskinesia in animal models of Parkinson's disease
Naomi P Visanji, Susan H Fox, Tom Johnston, et al.
Journal of Neurology
|
December 14, 2004
A 10 year retrospective audit of long-term apomorphine use in Parkinson's disease
Hilary L Tyne, Jan Parsons, Ann Sinnott, et al.
Page
of 18
Search research articles
Search
Showing results (81-90 of 178) with videos related to
Sort By:
Page
of 18
Current Neurology and Neuroscience Reports
|
June 12, 2009
New insights into the organization of the basal ganglia
James B Koprich, Tom H Johnston, Philippe Huot, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
September 9, 2010
The α₂ adrenergic antagonist fipamezole improves quality of levodopa action in Parkinsonian primates
Tom H Johnston, Susan H Fox, Matthew J Piggott, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
March 15, 2006
Histamine H3 receptor agonists reduce L-dopa-induced chorea, but not dystonia, in the MPTP-lesioned nonhuman primate model of Parkinson's disease
Jordi Gomez-Ramirez, Tom H Johnston, Naomi P Visanji, et al.
Current Neurology and Neuroscience Reports
|
January 20, 2017
Integrating Patient Concerns into Parkinson's Disease Management
Shen-Yang Lim, Ai Huey Tan, Susan H Fox, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 17, 2010
Reduction of L-DOPA-induced dyskinesia by the selective metabotropic glutamate receptor 5 antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease
Tom H Johnston, Susan H Fox, Matthew J McIldowie, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
January 16, 2018
Botulinum Toxin Type A for Pain in Advanced Parkinson's Disease
Veronica Bruno, Maria Eliza Freitas, Deborah Mancini, et al.
JAMA Neurology
|
September 23, 2024
Four-Repeat Tau Seeding in the Skin of Patients With Progressive Supranuclear Palsy
Ivan Martinez-Valbuena, M Carmela Tartaglia, Susan H Fox, et al.
Neurobiology of Aging
|
November 6, 2010
Regulation of cortical and striatal 5-HT1A receptors in the MPTP-lesioned macaque
Philippe Huot, Tom H Johnston, James B Koprich, et al.
Neurobiology of Disease
|
January 3, 2009
Dopamine D3 receptor stimulation underlies the development of L-DOPA-induced dyskinesia in animal models of Parkinson's disease
Naomi P Visanji, Susan H Fox, Tom Johnston, et al.
Journal of Neurology
|
December 14, 2004
A 10 year retrospective audit of long-term apomorphine use in Parkinson's disease
Hilary L Tyne, Jan Parsons, Ann Sinnott, et al.
Page
of 18